Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Antibodies for Drug-Metabolizing Enzymes
Hyesook, Kim
Oxford Biomedical Research, Inc., Rochester Hills, MI, United States
Search 34 grants from Kim Hyesook
Search grants from Oxford Biomedical Research, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Regulatory Validation of Standardized Clinical Immunohistochemistry Controls
Cholera Transmission in Gressier Region, Haiti
Cognitive Behavioral Skills Training for Schizophrenia
Mucosal Immune Response to HIV GP120 Vaccines
Regulation of Fibrinogen Synthesis - Role of Hsf/Ifn B2
Recently added grants:
Directing the metabolic fate of CAR T cells
(PQ5) Consequences of imbalanced mitophagy and mitochondrial biogenesis in cancer
?-3 fatty acid-derived mediators promote resolution of inflammation: Uncovering new strategies for preventing colitis-associated colon cancer
Project 1: Effect of Iron Deprivation on H. pylori-induced Gastric Carcinogenesis
Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapy
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43ES031002-001
Application #
3639950
Study Section
Project Start
1993-09-30
Project End
Budget Start
1993-12-20
Budget End
1994-03-31
Support Year
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
Oxford Biomedical Research, Inc.
Department
Type
DUNS #
City
Rochester Hills
State
MI
Country
United States
Zip Code
48309
Related projects
NIH 1994
N43 ES
Development of Antibodies for Drug-Metabolizing Enzymes
Hyesook, Kim / Oxford Biomedical Research, Inc.
NIH 1993
N43 ES
Development of Antibodies for Drug Metabolizing Enzymes
Hyesook, Kim / Oxford Biomedical Research, Inc.
Comments
Be the first to comment on Kim Hyesook's grant